first month tirzepatide Average Monthly Weight Loss on First Month on Tirzepatide (Zepbound)

Sources Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Fda Clarifies Policies For Compounders As National Glp-1 Supply Begins To Stabilize (April 28, 2025) Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial (March 23, 2019) Lilly's Zepbound (Tirzepatide) Superior To Wegovy (Semaglutide) In Head-To-Head Trial Showing An Average Weight Loss Of 20.2% Vs

conducted a retrospective cohort study with data spanning more than 5year followup period with patients with T2DM or obesity

The rebound effect is not unique to tirzepatideit mirrors patterns seen with other GLP-1 medications like semaglutide

8 People watching this product now